A new form of vaccine called "Acellular vaccine (ACV)" that contained a limited number of defined proteins, was introduced in many developed countries using this vaccine vaccinating their populations for nearly 14 years. This vaccine replaced WCV to avoid the side effects of the latter vaccine in some countries (4) . Although the incidence of pertussis was successfully reduced after the introduction of both types of vaccines, the disease is still endemic and the resurgence of pertussis has been revealed in many countries even with high vaccination coverage (5) (6) (7) (8) . It has been suggested that among the several reasons of this reemergence (9), genetic diversity in virulence factors is one of the major causes that has affected vaccine efficacy (10-13).
Pertussis toxin (Ptx) and pertactin (Prn) are two virulence factors used in ACV vaccine which confer protective immunity in animals and humans (14) .
The gene encoding fimbriae is the other virulence gene which is also subject to variation due to mutation. DNA sequencing of the genes encoding the region 1 of pertactin, S1 subunit of pertussis toxin, fimbriae 3 and adenylate cyclase toxin was performed using PCR fragments by using the previously described primers (Table 1) 
